Epidural Spinal Cord Stimulation for Restoring Walking in Spinal Cord Injury
Safety and Efficacy of Epidural Spinal Cord Stimulation for Restoring Walking in Spinal Cord Injury
1 other identifier
interventional
12
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of Epidural Electrical Stimulation (EES) combined with rehabilitation training for the reconstruction of walking in patients with chronic spinal cord injury (SCI) classified as AIS C-D. The main questions it aims to answer are: Does the intervention of EES combined with rehabilitation significantly improve walking capacity? Is the combined intervention a safe approach for this patient population? Researchers will compare participants' functional assessments before EES implantation and at 1, 3, 6, 9, and 12 months post-implantation to evaluate the longitudinal effects. The primary assessments include the Walking Index for Spinal Cord Injury II (WISCI II), the 10-Meter Walk Test (10mWT), and the 6-Minute Walk Test (6minWT). Secondary outcome measures encompass the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), the Spinal Cord Independence Measure (SCIM III), the Functional Independence Measure (FIM), the Modified Ashworth Scale (MAS), the Penn Spasm Frequency Scale, and pain Visual Analogue Scale (VAS) scores. Neurophysiological and imaging evaluations, including electromyography (EMG), motor evoked potentials (MEPs), somatosensory evoked potentials (SEPs), and positron emission tomography-computed tomography (PET-CT), will be conducted preoperatively and at 6 months postoperatively to explore the mechanisms of neuroplasticity. Participants will: Undergo surgical implantation of an EES device. Receive personalized EES parameter programming combined with rehabilitation training (≥2 hours daily) post-operatively. Complete a series of standardized functional and clinical outcome assessments at scheduled follow-up intervals. Undergo scheduled neurophysiological and metabolic imaging studies. Report any adverse events throughout the study duration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedStudy Start
First participant enrolled
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
December 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
December 29, 2025
December 1, 2025
1.5 years
December 12, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Adverse Events (AEs)
The incidence, severity, and relationship to the intervention of all AEs . All AEs will be defined, recorded, and graded according to the International Council for Harmonisation Good Clinical Practice guidelines. Serious adverse events will be reported specifically based on established criteria. This assessment will comprehensively cover all safety concerns related to the surgical procedure (epidural stimulator implantation), the electrical stimulation itself (across various parameter sets).
Entire study period from implantation to the 13-month postoperative follow-up.
WISCI II (Walking Index for Spinal Cord Injury II)
The WISCI II evaluates walking ability in spinal cord injury patients. It has 21 levels (0-20), with scores based on mobility aids and assistance needed. A score of 0 means no walking; 20 indicates independent walking without aids.
baseline, and 2, 4, 7, 13 monthes after surgery.
Spinal Cord Independence Measure III (SCIM III)
SCIM III is a disease-specific, validated assessment tool designed to evaluate the functional independence of individuals with spinal cord injury in performing essential activities of daily living, self-care, mobility, and respiration/management. It is tailored to reflect the unique challenges and priorities of the SCI population. The SCIM III consists of 19 items across three subscales: Self-care subscale (0-20 points): Includes feeding, grooming, bathing, and dressing. Respiration and sphincter management subscale (0-40 points): Covers respiration, bladder management, and bowel management. Mobility subscale (0-40 points): Assesses mobility in room and toilet, indoors and outdoors mobility, and stair management. The total score ranges from 0 to 100 points, with higher scores indicating greater functional independence.
baseline, and 2, 4, 7, 13 months after surgery
Secondary Outcomes (7)
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
baseline, and 2, 4, 7, 13 monthes after surgery
Functional Independence Measure (FIM)
baseline, and 2, 4, 7, 13 months after surgery
The 10-Meter Walk Test (10m-WT)
baseline, and 2, 4, 7, 10, 13 monthes after surgery
The 6-Minute Walk Test (6min-WT)
baseline, and 2, 4, 7, 10, 13 monthes after surgery
Modified Ashworth Scale (MAS)
baseline, and 2, 4, 7, 13 monthes after surgery
- +2 more secondary outcomes
Other Outcomes (4)
Surface Electromyography (EMG)
baseline, and 7 monthes after surgery
Motor Evoked Potentials (MEPs)
baseline, and 7 monthes after surgery
Somatosensory Evoked Potentials (SEPs)
baseline, and 7 monthes after surgery
- +1 more other outcomes
Study Arms (1)
Epidural spinal cord stimulation + Standard Rehabilitation
EXPERIMENTALParticipants receive the epidural spnial cord stimulation combined with individualized standard rehabilitation therapy for 12 months.
Interventions
PET-CT is an advanced hybrid imaging modality that combines metabolic information from positron emission tomography with anatomical details from computed tomography.
Epidural spinal cord stimulation is a medical technology that involves delivering controlled electrical impulses to the spinal cord through electrodes implanted in the epidural space-the area between the outermost membrane of the spinal cord (dura mater) and the vertebrae. This technique aims to modulate the activity of spinal neural networks, thereby regulating neurological functions and promoting functional recovery, particularly in individuals with spinal cord injuries or certain neurological disorders.
A structured, multidisciplinary rehabilitation program designed to improve motor function, mobility, and independence in participants with paralysis. The therapy typically includes physical Therapy and occupational Therapy.
SEPs are electrophysiological responses recorded from the central or peripheral nervous system following electrical stimulation of sensory nerves. They assess the functional integrity of somatosensory pathways.
MEPs are electrophysiological responses elicited by transcranial magnetic stimulation or electrical stimulation of the motor cortex, recorded from peripheral muscles or the spinal cord. They evaluate the integrity of corticospinal tracts.
DTI is an advanced MRI technique that maps white matter tracts by measuring the directionality (anisotropy) and magnitude of water molecule diffusion in neural tissues. It provides quantitative metrics of fibers.
Eligibility Criteria
You may qualify if:
- Age between 16 and 65 years.
- Diagnosed with traumatic spinal cord injury for ≥ 6 months and ≤ 36 months.
- American Spinal Injury Association Impairment Scale (AIS) grade C-D.
- Spinal cord injury level above T10;
- Walking Index for Spinal Cord Injury II (WISCI II) score \< 13.
- Completion of a standard conventional rehabilitation program prior to enrollment.
- Preserved upper limb function sufficient for self-propelling a manual wheelchair.
- Sitting balance grade ≥ 1.
- Ability to elicit clear electromyographic responses in lower limb muscles (e.g., rectus femoris, biceps femoris, gastrocnemius, tibialis anterior) upon transcutaneous electrical spinal cord stimulation at the T12-L1 vertebral levels.
- Willingness to voluntarily participate, and commitment to compliance with all necessary postoperative rehabilitation, assessments, and follow-up visits.
You may not qualify if:
- History of myocardial infarction or stroke within the past 6 months.
- Diagnosis of psychiatric disorders with active suicidal ideation or risk.
- Current pregnancy or planned pregnancy during the study period.
- Bleeding tendency or coagulopathy (prothrombin time ≥18 seconds).
- History of alcohol or substance abuse or dependence.
- Intellectual disability, cognitive impairment, or personality disorders.
- Other chronic medical conditions that may interfere with rehabilitation (e.g., unhealed severe fractures, hepatic or renal failure, severe anemia, etc.).
- Implantation of cardiac pacemakers, cardioverters, or defibrillators.
- Any other condition deemed inappropriate for participation by the investigators.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Junming Zhu
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 29, 2025
Study Start
December 12, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
December 29, 2025
Record last verified: 2025-12